17-N-allylamino-17-demethoxygeldanamycin

From Wikipedia, the free encyclopedia

You have new messages (last change).

17-N-allylamino-17-demethoxygeldanamycin is a substance that is being studied in the treatment of cancer, specific young patients with certain types of leukemia or solid tumors, especially kidney tumors. As of June 2005, 17-N-allylamino-17-demethoxygeldanamycin is undergoing Phase 1 and Phase 2 clinical trials. It belongs to the family of drugs called antitumor antibiotics.

[edit] External links

 This medical treatment article is a stub. You can help Wikipedia by expanding it.
 This article about an organic compound is a stub. You can help Wikipedia by expanding it.
Retrieved from "http://en.wikipedia.org../../../1/7/-/17-N-allylamino-17-demethoxygeldanamycin_86af.html"